LivDerm

 

LivDerm
E

CSCC Management Update: Why Is CCPDMA for High Risk CSCC Important? What Is the Efficacy of the New PD-1 Inhibitors?

By LivDerm FEATURING Emily Ruiz
By LivDerm FEATURING Emily Ruiz
55 views
February 18, 2021
Comments 0
Login to view comments. Click here to Login
2021 South Beach Symposium
02:58

Welcome Message & Highlights of the South Beach Symposium

LivDerm

M. Nestor

16 views
13:52

AMA Dermatology Coding Updates for 2021: What Are the Changes in Rei…

LivDerm

M. Kaufmann

558 views
09:39

Update on Biologic Therapies in Dermatology: Understanding the IL-17…

LivDerm

D. E. Cohen

154 views
10:15

Aesthetic & Clinical Approaches to Melasma: What are the Pre/Post Tr…

LivDerm

A. Mcmichael

485 views
10:16

Post-Inflammatory Hyperpigmentation in Skin of Color: How to Choose …

LivDerm

V. Callender

588 views
03:23

CSCC Management Update: Why Is CCPDMA for High Risk CSCC Important? …

LivDerm

E. Ruiz

55 views
06:17

Dermoscopy in Melanoma Screening: How to Differentiate Melanocytic L…

LivDerm

D. J. Goldberg

1.3K views
06:52

Innovations in Skin Cancer Diagnosis: Is Actinic Keratosis a Precurs…

LivDerm

C. Cockerell

363 views
05:30

Wound Care Management: Reducing Scarring Through Reducing Tension & …

LivDerm

R. Kisner

174 views
05:03

Off Label Prescribing: Etanercept for SJS, Dupilumab for Prurigo Nod…

LivDerm

L. Stein Gold

100 views
08:59

Differences in Radiation Therapies for Skin Lesions: What Is the Eff…

LivDerm

M. Nestor

145 views
07:20

2021 LivDerm Update on Skin Cancer Diagnosis & Management: What Are …

LivDerm

D. Rigel

171 views